Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

Osvyrti is suppled as a 60mg/mL single-dose prefilled syringe for SC administration and Jubereq is supplied as 120mg/1.7mL single-dose vial for SC administration.

Increased rate of major bleeding and lower mortality rates observed, resulting in greater net clinical benefit.

According to the US Department of Health and Human Services, research plans to investigate all the possible causes of autism are in the works.

Tonmya now available for fibromyalgia; safety warnings for DMD treatment; mitapivat shows mixed results in sickle cell disease trial; Redemplo approved for familial chylomicronemia syndrome; Hyrnuo ...

The prevalence of childhood hypertension nearly doubled between 2000 and 2020, from 3.40 to 6.53% in boys and from 3.02 to 5.82% in girls. HealthDay News — The prevalence of childhood hypertension is ...

Proportion of physicians with MHSU care stable prepandemic, then increased, with larger increases seen during first two years of pandemic.

Darzalex Faspro ® is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase that increases permeability of the subcutaneous ...

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...

The FDA also approved an every 4 week dosing regimen across all approved indications for patients who may not maintain a response on extended dosing intervals following successful initial treatment.

HealthDay News — Most countries involved in clinical trials for US Food and Drug Administration approvals do not gain timely physical access to the medicines that they help evaluate, according to a ...